September 2017 - Page 2 of 3

WednesdaySep 20, 2017 3:25 pm

Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) is “One to Watch”

Amid a continued boom in the growing cannabis sector, Canada is moving rapidly toward legalization as the U.S. continues to foot drag at the federal level, leading many sector analysts to conclude that it’s the Canadian companies who might benefit the most as an underlying shift toward medical and recreational use continues. Out of a tiny handful of just 58 Health Canada-licensed producers, vertically integrated Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) stands out as a one of the fastest growing cultivators and pharma developers, having also obtained authorization to produce cannabis oils. While sales of dried marijuana intended for smoking…

WednesdaySep 20, 2017 10:07 am

The Green Organic Dutchman Rides on Quality Medical Cannabis, Private Placement and Strong Leadership

The Green Organic Dutchman (“TGOD”), a 100-percent owned subsidiary of The Green Organic Dutchman Holdings Ltd., produces high-quality medical marijuana. Its organic medical cannabis is farm grown and pesticide-free. There are many factors in favor of the company. The demand in a legal national market, consumer preference for organic foods and products of all kinds and a recent $20 million private placement are all positive signs. Also, TGOD is among a select group of companies licensed to cultivate medical cannabis by Health Canada under the Access to Cannabis for Medical Purposes Regulations. Those interested in investing should contact TGOD directly…

TuesdaySep 19, 2017 4:10 pm

The Green Organic Dutchman Holdings Ltd. Announces $20M Private Placement as Company Moves toward Expansion

Company has, to date, raised $41.5 million and has more than 2,400 shareholders Has one of the largest licensed land parcels in Canada, situated on 100 acres Offers organically grown, pesticide-free medical marijuana under Canada’s ACMPR The Green Organic Dutchman Holdings Ltd. (“TGOD”), a Canadian company engaged in producing farm-grown, high-quality organic medical cannabis using craft growing, all natural, organic principles, announced on September 11 (http://cnw.fm/jHbs0) that it has entered into an agreement with a syndicate led by PI Financial Corp. to complete a private placement offering of units. The syndicate will offer, on a commercially reasonable effort basis, 4,242,500…

TuesdaySep 19, 2017 3:33 pm

At ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF), Medicinal Cannabinoid Quality and Safety are Founding Principles

Producer of consistent, standardized medicinal cannabis Menu of cannabis strains with varying CBD:THC ratios ABcann’s CBD-Med is one of Canada's highest-CBD products In an interview with Cantech Letter (http://cnw.fm/g2AtB), Aaron Keay, CEO of ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF), talked about the factors that triggered the genesis of the company, one of Canada’s trailblazing producers of medicinal cannabis. Ken Clement, the founder of ABcann, with his wealth of experience and knowledge, had observed the variability in consistency and potency of cannabis that was currently available. Although, in general, not much of a bother to recreational users, to those using cannabis…

MondaySep 18, 2017 3:08 pm

India Globalization Capital, Inc. (NYSE: IGC) Reports Promising Progress of Cannabis-Based Alzheimer’s Drug Candidate

IGC is the only publicly traded cannabis stock with patent filings for treating Alzheimer’s disease Company has a first-mover advantage in phytocannabinoid-based combination therapy Alzheimer’s is America’s most expensive disease, costing the country an estimated $259 billion in 2017 It is considered America’s most expensive disease, projected to cost an estimated $259 billion in the United States in 2017 and as much as $1.1 trillion by 2050 (http://cnw.fm/L9huG). It is not cancer, and it is not AIDS. It is Alzheimer’s disease. This devastating chronic neurodegenerative disease is the most common cause of dementia among older adults and is the sixth-leading…

FridaySep 15, 2017 9:31 am

ChineseInvestors.com, Inc. (CIIX) Sets Goal of Greater than 100% Gain in FY2018 Revenues

In FY2017, the company’s investor relations business grew 130%, and its subscriptions business rose by 57% Warren Wang, founder and chief executive officer of CIIX, sets goal of greater than 100% gain in sales in FY2018 and cost-cutting to achieve profitability Company excited about its expansion of auxiliary services into the digital currency industry; Wang says that market will offer long-term opportunities ChineseInvestors.com, Inc. (OTCQB: CIIX) recorded a skyrocketing 76% year-over-year operating revenues increase for its fiscal year ended May 31, 2017. The company’s two divisions exhibited double-digit and triple-digit growth in FY2017. The investor relations business grew 130%, while…

ThursdaySep 14, 2017 2:31 pm

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Builds Moat around Proprietary Biosynthesis Technology

Proprietary biosynthesis process to produce cannabinoids Provisional patent application filed Cost-effective methodology to produce trace cannabinoids If you have any doubt that InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is on the right track as it moves to protect its biosynthesis technology for cannabinoids, then a word from a famed figure may make you change your mind. Known worldwide for his investing prowess, Warren Buffett has said, “I don't want a business that's easy for competitors. I want a business with a moat around it with a very valuable castle in the middle” (http://cnw.fm/ehB50). Naturally, the Sage of Omaha was…

WednesdaySep 13, 2017 3:58 pm

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Oral CBD Product to Be Tested by the University of British Columbia

The University of British Columbia (UBC) will conduct a double-blind study of Lexaria’s TurboCBD™ oral ingestion product TurboCBD™ masks foul tastes, protects pharmaceutical ingredients during stomach passage and increases intestinal absorption by 5-10x The UBC study will include 24 volunteers and test their cognitive and cardiovascular function after single doses and after seven days of administration Traditionally, cannabidiol (CBD) is ingested via inhalation, which can harm the lungs, and many edible products contain unwanted sugars or sweeteners. Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has revolutionized oral intake with its TurboCBD™ product. Engineered to increase absorption through the intestinal tract,…

WednesdaySep 13, 2017 12:17 pm

Are Charity Organizations Turning Away Donations from Cannabis Companies?

No one can deny there’s a need for volunteers and donations when the top news of the day features one natural disaster after another. But for some business owners, like those in the highly regulated cannabis industry, it’s not that simple. Sometimes their proffered donations aren’t seen as a positive. Instead, they’re viewed as a liability, and one that many charity organizations aren’t willing to accept. In an article published Monday in Forbes, an attempt by one cannabis company to donate some of its profits to various charitable organizations is described as less than successful. “It felt like a slap…

TuesdaySep 12, 2017 3:55 pm

Algae Dynamics Corp. (ADYNF) Collaborating with Prominent Neuroscientist to Research Benefits of Cannabis Oil for Mental Health Disorders

Partnership between Algae Dynamics and Dr. Steven Laviolette focuses on medical benefits of cannabis and hemp oils for various mental health disorders Canada is moving to legalize cannabis throughout the country in 2018, which could radically change research playing field Canadian cannabis oil extraction market projected to reach $1.5 billion by 2020 Algae Dynamics Corp. (OTCQB: ADYNF), a Canadian company focused on the development of proprietary research and products derived from cannabis and hemp oils, has begun a collaborative relationship with one neuroscientist who is looking deep within the brain for answers to some of the world’s most pressing mental…

News and publishing service for hemp related companies

Contact us: 303.498.7722

Month: September 2017